Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism -- analysis by mathematical modeling
From MaRDI portal
Publication:1642627
DOI10.1016/J.JTBI.2018.04.035zbMath1397.92340OpenAlexW2800409900WikidataQ88503717 ScholiaQ88503717MaRDI QIDQ1642627
Andrey V. Kolobov, Maxim B. Kuznetsov
Publication date: 15 June 2018
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2018.04.035
Related Items (5)
Analysis of anticancer efficiency of combined fractionated radiotherapy and antiangiogenic therapy via mathematical modelling ⋮ Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers ⋮ A reduced model of cell metabolism to revisit the glycolysis-OXPHOS relationship in the deregulated tumor microenvironment ⋮ Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model ⋮ Optimization of antitumor radiotherapy fractionation via mathematical modeling with account of 4 R's of radiobiology
Uses Software
Cites Work
- Unnamed Item
- Modeling the inhibition of breast cancer growth by GM-CSF
- A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
- Mathematical modelling of chemotherapy combined with bevacizumab
- The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems
- New insights into vascular collapse and growth dynamics in solid tumors
- How tumour-induced vascular changes alter angiogenesis: insights from a computational model
- The Role of Cell Motility in Metastatic Cell Dominance Phenomenon: Analysis by a Mathematical Model
- Flux-corrected transport. I: SHASTA, a fluid transport algorithm that works
This page was built for publication: Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism -- analysis by mathematical modeling
